State of Wisconsin Investment Board’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,100
Closed -$93K 2019
2020
Q2
$93K Buy
+12,100
New +$92.6K ﹤0.01% 1649
2020
Q1
Sell
-51,100
Closed -$622K 1761
2019
Q4
$622K Hold
51,100
﹤0.01% 1369
2019
Q3
$590K Hold
51,100
﹤0.01% 1273
2019
Q2
$510K Buy
51,100
+1,100
+2% +$11.9K ﹤0.01% 1321
2019
Q1
$644K Buy
50,000
+14,500
+41% +$216K ﹤0.01% 1278
2018
Q4
$539K Buy
35,500
+500
+1% +$9.53K ﹤0.01% 1291
2018
Q3
$700K Hold
35,000
﹤0.01% 1319
2018
Q2
$682K Buy
35,000
+9,000
+35% +$199K ﹤0.01% 1291
2018
Q1
$524K Hold
26,000
﹤0.01% 1290
2017
Q4
$344K Hold
26,000
﹤0.01% 1340
2017
Q3
$480K Hold
26,000
﹤0.01% 1305
2017
Q2
$478K Buy
+26,000
New +$515K ﹤0.01% 1292

Other funds holding AMAG

State of Wisconsin Investment Board's AMAG Position: Q3 2020 in Review

State of Wisconsin Investment Board sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 12,100 shares — an estimated $93K sold.

State of Wisconsin Investment Board first reported a position in AMAG in Q2 2017 and held it in 12 quarters. The position peaked at $700K in Q3 2018. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.

  • State of Wisconsin Investment Board reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 12,100 AMAG Pharmaceuticals shares in Q3 2020, an estimated $93K.
  • State of Wisconsin Investment Board first reported a position in AMAG Pharmaceuticals in Q2 2017 and held it in 12 quarters.
  • State of Wisconsin Investment Board's AMAG Pharmaceuticals position peaked at $700K in Q3 2018.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2020, filed 16 Nov 2020.